Harmony Biosciences Announces CFO Departure and Interim Appointment, Reaffirms 2026 Revenue Guidance

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) announced that Glenn Reicin will step down as Chief Financial Officer, effective July 16, 2026. Stephen Mollichella, the company's Senior Vice President and Controller, has been appointed Interim Principal Financial Officer. The company also issued a press release announcing preliminary net product revenue for the second quarter of 2026 and reaffirmed its guidance for 2026 net product revenue.